“The most common manifestations of that disorder — pain, redness, dry eye, corneal neovascularization or angiogenesis, and even endothelial disease — are linked, as you’ll see, with ...

Creative Biolabs Creative Biolabs has recently expanded its research in non-transgenic rodent models to meet the growing diversity of non-c ...

Although cures for age-related macular degeneration are elusive, the case for prevention through nutrition looks strong and ...

Digital device use and reading distance are linked to changes in choroidal thickness among Tokyo children. The study finds ...

Diabetic retinopathy, a common complication of diabetes, can damage the retina and lead to blindness. Early symptoms like ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Lupin partners with SteinCares to commercialize biosimilar ranibizumab in Latin America, enhancing retinal care access in the region.

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data anticipated in 3Q 2025 ---- Cash resources of $42.2 m ...

Retinal drugs market growth driven by aging population, rising AMD prevalence, and advances in ophthalmic drug delivery and retinal disease treatment innovation.

Objective: Choroidal neovascularization (CNV) represents the predominant ... After dilating pupils with compound tropicamide eye drops (Shenyang Sinqi Pharmaceutical Co., Ltd.), C57BL/6 mice underwent ...

Pegcetacoplan and avacincaptad pegol are associated with significant overreporting of adverse events, highlighting the need for close monitoring.